Overview

Safety and Efficacy Study of Hydromorphone and Morphine

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To compare a standard weight-based dose of intravenous (IV) hydromorphone (Dilaudid) to a standard weight-based dose of IV morphine in adults presenting to the Emergency Department (ED) with acute severe pain.
Phase:
Phase 2
Details
Lead Sponsor:
Chang, Andrew, M.D.
Montefiore Medical Center
Treatments:
Hydromorphone
Morphine